Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

PURPOSE: Generally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Korean J Pediatr
Auteurs principaux: Hwang, Tae-Woong, Kim, Sung-Ook, Lee, Sang-Yun, Kim, Seong-Ho, Choi, Eun-Young, Jang, So-Ick, Park, Su-Jin, Kwon, Hye-Won, Lim, Hyo-Bin, Lee, Chang-Ha, Choi, Eun-Seok
Format: Artigo
Langue:Inglês
Publié: The Korean Pediatric Society 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118504/
https://ncbi.nlm.nih.gov/pubmed/27895692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2016.59.11.446
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires